Skip to main content

Headlines

Ascletis Announces Positive Interim Data From Phase IIb Expansion Cohort Of ASC22 For CHB
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
UNITY Biotechnology Reports Encouraging Results From Phase 2 ENVISION Study Of UBX1325
posted:
by: Nasdaq AAPL Apple
#channels:: #All, #Business, #Nasdaq, #Technology, #Stocks, #AAPL, #Apple
Ionis Reports Positive Results From Phase 3 Study Of Olezarsen In Familial Chylomicronemia Syndrome
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Roivant Reports Positive Initial Phase 1 Data For IMVT-1402
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Merck Says Phase 3 KEYNOTE-A39/EV-302 Trial Meets Dual Primary Endpoints
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AstraZeneca Reports Positive Results From Phase III Trial With Datopotamab Deruxtecan
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Seelos Therapeutics: SLS-002 Phase II Study Fails To Meet Primary Endpoint On Limited Sample Size
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Pulmatrix Receives Study May Proceed Letter From FDA For Phase 2 Study To Evaluate PUR3100
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Arcutis' INTEGUMENT-PED Phase 3 Study Of Roflumilast Cream 0.05% Meets Primary Goal
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Volvo Cars To Completely Phase Out Diesels By Early 2024
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Astellas Pharma Announces Positive Results From Phase 3 Trial Of Izervay In Geographic Atrophy
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Allergan Aesthetics: Second Phase 3 Study With OnabotulinumtoxinA Meets Endpoints
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Aclaris Reports Positive Phase 1 MAD Trial Results Of ATI-2138; To Progress To Phase 2a Trials
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Global climate protests demand world leaders phase out fossil fuels
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets